Compare medications
Choose two to four medications to see them side by side. This is a starting point for a conversation with your prescriber, not a recommendation of which one to choose.
| Attribute | Zepbound tirzepatide | Wegovy semaglutide | Ozempic semaglutide | Mounjaro tirzepatide |
|---|---|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide | Semaglutide | Tirzepatide |
| Manufacturer | Eli Lilly | Novo Nordisk | Novo Nordisk | Eli Lilly |
| FDA-approved indications |
|
|
|
|
| Injection frequency | Once weekly | Once weekly | Once weekly | Once weekly |
| General cost category | Typically among the higher list-price GLP-1 options before insurance or savings programs | Typically among the higher list-price GLP-1 options before insurance or savings programs | Typically among the higher list-price GLP-1 options before insurance or savings programs | Typically among the higher list-price GLP-1 options before insurance or savings programs |
| Commonly discussed for | chronic weight management | chronic weight management | diabetes | diabetes |
General cost category and commonly-discussed-for labels are editorial summaries pending full source verification — see each medication's guide for detail. [Medical review required before publication]
Stay ahead of what's changing in GLP-1s
GLP-1 prices, insurance coverage, research, stories, medication news, and available options can change quickly.
Join The GLP List for useful updates on the changes that actually matter — without the hype or noise.
Signing up doesn't start treatment or create a patient relationship — it just adds you to our updates list.